Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | PRKCA | P17252 | 4/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26973 | 1.00 | MAPT (0.70) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL4797376 | 1.00 | MAPT (0.70) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL16701295 | 1.00 | MAPT (0.70) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL571263 | 1.00 | MAPT (0.70) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL20263545 | 1.00 | MAPT (0.70) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL1695881 | 1.00 | MAPT (0.70) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL1246202 | 0.98 | MAPT (0.67) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL9011176 | 0.92 | MAPT (0.58) | MAPTMAPK1LMNAPRKCAPRKCE | |
| Propene SCHEMBL20819808 | 0.92 | MAPT (0.60) | MAPTMAPK1LMNAPRKCAPRKCE | |
| SCHEMBL144890 | 0.90 | PRKCA (0.66) | MAPTMAPK1LMNAPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 911 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250049046-A1 | FORMULA AND PROCESS FOR PRODUCING FROZEN SHEETED DOUGH | RICH PRODUCTS CORPORATION | 2025-02-13 | — | — | US | claimed |
| US-12161123-B2 | Formula and process for producing frozen sheeted dough | RICH PRODUCTS CORPORATION (US) | 2024-12-10 | — | — | US | claimed |
| US-20240156765-A1 | METHODS OF NEUROPROTECTION AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2024-05-16 | — | — | US | claimed |
| US-20240050371-A1 | W/O/W MICROEMULSIONS FOR OCULAR ADMINISTRATION | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2024-02-15 | — | — | US | claimed |
| US-11826467-B2 | W/O/W microemulsions for ocular administration | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2023-11-28 | — | — | US | claimed |
| CN-114901069-B | Octenidine salt antimicrobial medical articles | 3M创新有限公司 | 2023-10-20 | — | — | CN | claimed |
| US-20230060820-A1 | OCTENIDINE SALT ANTIMICROBIAL MEDICAL ARTICLES | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-03-02 | — | — | US | claimed |
| EP-3319456-B1 | REDUCED-FAT FROZEN CONFECTION | CARGILL INC (US) | 2022-08-31 | — | — | EP | claimed |
| CN-114901069-A | Octenidine salt antimicrobial medical articles | 3M创新有限公司 | 2022-08-12 | — | — | CN | claimed |
| US-11400048-B2 | Pharmaceutical oil-in-water nano-emulsion | SYNERGIA BIO SCIENCES PRIVATE LIMITED (IN) | 2022-08-02 | — | — | US | claimed |
| EP-0187266-B1 | SOLID SILICONE DEFOAMING AGENT AND METHOD FOR ITS PRODUCTION | Toray Silicone Company Limited (JP) | 1988-03-16 | — | — | EP | claimed |
| US-4719034-A | NONIONIC SURFACTANT, WATER-SOLUABLE POLYMER, SILICA AND SILICONE OIL | TORAY SILICONE CO., LTD. (JP) | 1988-01-12 | — | — | US | claimed |
| EP-0187266-A2 | Solid silicone defoaming agent and method for its production | Toray Silicone Company Limited (JP) | 1986-07-16 | — | — | EP | claimed |
| US-4468408-A | LIPOPHILIC AND HYDROPHILIC EMULSIFIERS | NABISCO BRANDS, INC. (US) | 1984-08-28 | — | — | US | claimed |
| US-4456626-A | FAT OR OILS WITH EMULSIFIER OF PROPYLENE GLYCOL MONO-FATTY ACID ESTER AND POLYGLYCEROL ESTER | THE PROCTER & GAMBLE COMPANY (US) | 1984-06-26 | — | — | US | claimed |
| US-4419377-A | Cake mix containing a lipophilic emulsifier system | THE PROCTER & GAMBLE COMPANY (US) | 1983-12-06 | — | — | US | claimed |
| US-4396635-A | SUGARS, FOODS, FLOUR, EMULSIFIERS | THE PROCTER & GAMBLE CO. (US) | 1983-08-02 | — | — | US | claimed |
| WO-1981001353-A1 | LOW-FAT LIQUID SPREAD AND PROCESS | STANDARD BRANDS INC (US) | 1981-05-28 | — | — | WO | claimed |
| WO-1981001354-A1 | LOW-FAT SPREAD AND PROCESS | STANDARD BRANDS INC (US) | 1981-05-28 | — | — | WO | claimed |
| US-3968266-A | Low density frozen dessert | THE PROCTER & GAMBLE COMPANY (US) | 1976-07-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240156765-A1 | METHODS OF NEUROPROTECTION AND USES THEREOF | NLN, BDNF, GAP43 | MAPT 447/4885MAPK1 3184/4885LMNA 398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.